207 related articles for article (PubMed ID: 35317170)
21. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
Shimanovich I; Petersen EE; Weyers W; Sitaru C; Zillikens D
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
[TBL] [Abstract][Full Text] [Related]
22. Dipeptidyl peptidase-4 inhibitor-associated anti-laminin-γ1 (p200) pemphigoid in a patient with psoriasis vulgaris.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Kayaba H; Sawamura D
J Dermatol; 2020 Jan; 47(1):e25-e26. PubMed ID: 31646656
[No Abstract] [Full Text] [Related]
23. Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases.
García-Díez I; Martínez-Escala ME; Ishii N; Hashimoto T; Mascaró Galy JM; Pujol RM; Herrero-González JE
Actas Dermosifiliogr; 2017; 108(1):e1-e5. PubMed ID: 27095685
[TBL] [Abstract][Full Text] [Related]
24. Case of subepidermal autoimmune bullous disease with psoriasis vulgaris reacting to both BP180 C-terminal domain and laminin gamma-1.
Ishida S; Takahashi K; Kanaoka M; Okawa T; Tateishi C; Yasukochi A; Ishii N; Li X; Hashimoto T; Aihara M
J Dermatol; 2015 Apr; 42(4):391-3. PubMed ID: 25683229
[TBL] [Abstract][Full Text] [Related]
25. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid.
Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M
Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077
[TBL] [Abstract][Full Text] [Related]
26. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
[TBL] [Abstract][Full Text] [Related]
27. IgA anti-p200 pemphigoid.
Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
[TBL] [Abstract][Full Text] [Related]
28. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
[TBL] [Abstract][Full Text] [Related]
29. Bullous Pemphigoid Masquerading as Erythrodermic Psoriasis.
De-Kaa NLP; Adefemi SA; Akuhwa RT; Fikin A; Atabo A
West Afr J Med; 2022 Dec; 39(12):1319-1323. PubMed ID: 36583972
[TBL] [Abstract][Full Text] [Related]
30. Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid.
Goletz S; Pigors M; Lari TR; Hammers CM; Wang Y; Emtenani S; Aumailley M; Holtsche MM; Stang FH; Weyers I; König IR; Has C; Radzimski C; Komorowski L; Zillikens D; Schmidt E
J Am Acad Dermatol; 2024 Apr; 90(4):790-797. PubMed ID: 37992812
[TBL] [Abstract][Full Text] [Related]
31. An attempt to develop mouse model for anti-laminin γ1 pemphigoid.
Koga H; Ishii N; Dainichi T; Tsuruta D; Hamada T; Ohata C; Karashima T; Furumura M; Hashimoto T
J Dermatol Sci; 2013 May; 70(2):108-15. PubMed ID: 23410740
[TBL] [Abstract][Full Text] [Related]
32. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
33. Interaction of Psoriasis and Bullous Diseases.
Dainichi T; Kabashima K
Front Med (Lausanne); 2018; 5():222. PubMed ID: 30135860
[TBL] [Abstract][Full Text] [Related]
34. A case of anti-laminin γ1 (p200) pemphigoid with psoriasis vulgaris successfully treated with apremilast.
Waki Y; Kamiya K; Komine M; Maekawa T; Murata S; Ishii N; Hashimoto T; Ohtsuki M
Eur J Dermatol; 2018 Jun; 28(3):413-414. PubMed ID: 29619999
[No Abstract] [Full Text] [Related]
35. Case of anti-laminin-gamma1 pemphigoid associated with psoriatic erythroderma.
Kaminaka C; Kanazawa N; Furukawa F; Hashimoto T
J Dermatol; 2010 Mar; 37(3):272-5. PubMed ID: 20507394
[No Abstract] [Full Text] [Related]
36. Immunoglobulin G deposition to nonhemidesmosomal lamina lucida and early neutrophil involvement are characteristic features in a case of anti-p200 pemphigoid.
Shimizu A; Funakoshi T; Ishibashi M; Yoshida T; Koga H; Hashimoto T; Amagai M; Ishiko A
Br J Dermatol; 2013 Mar; 168(3):647-55. PubMed ID: 22963596
[TBL] [Abstract][Full Text] [Related]
37. Anti-p200 pemphigoid (anti-laminin-γ1 pemphigoid) demonstrating pathergy.
McCarty M; Zillikens D; Fivenson D
Int J Womens Dermatol; 2015 Dec; 1(4):173-174. PubMed ID: 28491985
[TBL] [Abstract][Full Text] [Related]
38. Case of pemphigoid with immunoglobulin G antibodies to BP180 C-terminal domain and laminin-γ1 (p200) developed after pneumococcal vaccination.
Maki N; Hashimoto T; Yamada T; Ishii N; Tsuruta D; Demitsu T
J Dermatol; 2021 Jan; 48(1):101-105. PubMed ID: 32974956
[TBL] [Abstract][Full Text] [Related]
39. The Intriguing Links between Psoriasis and Bullous Pemphigoid.
Maronese CA; Cassano N; Genovese G; Foti C; Vena GA; Marzano AV
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615129
[TBL] [Abstract][Full Text] [Related]
40. Histopathology of anti-p200 pemphigoid.
Rose C; Weyers W; Denisjuk N; Hillen U; Zillikens D; Shimanovich I
Am J Dermatopathol; 2007 Apr; 29(2):119-24. PubMed ID: 17414431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
